Company Sector
Rare Disease Gene Therapy
Rare Disease Gene Therapy is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Rare Disease Gene Therapy, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.
Why watch Rare Disease Gene Therapy
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Rare Disease Gene Therapy news
The latest feed items from companies currently grouped under Rare Disease Gene Therapy.
- 01
- 02
- 03
RCKTRocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease
Source: Rocket Pharmaceuticals
- 04
- 05
EDITEditas Medicine Reports Inducement Grants to New Chief Medical Officer
Source: Editas Medicine
- 06
PHARPharming Group to participate in September investor conferences
Source: Pharming Group
- 07
EDITEditas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Source: Editas Medicine
- 08
KRYSKrystal Biotech to Present at 2026 Cantor Global Healthcare Conference
Source: Krystal Biotech
- 09
RCKTRocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Source: Rocket Pharmaceuticals
- 10
ABEOAbeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Source: Abeona Therapeutics
- 11
EDITEditas Medicine to Participate in Upcoming Investor Conferences
Source: Editas Medicine
- 12
ABEOAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Abeona Therapeutics
- 13
- 14
ABEOAbeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
Source: Abeona Therapeutics
- 15
- 16
RCKTRocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
Source: Rocket Pharmaceuticals
- 17
- 18
ABEOAbeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
Source: Abeona Therapeutics
- 19
EDITEditas Medicine Announces Second Quarter 2026 Results and Business Updates
Source: Editas Medicine
- 20
Companies in Rare Disease Gene Therapy
11 companies tagged with Rare Disease Gene Therapy.
Frequently Asked Questions
What does the Rare Disease Gene Therapy sector include?
Rare Disease Gene Therapy is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Rare Disease Gene Therapy, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.
How many companies are currently tagged with Rare Disease Gene Therapy?
11 companies are currently grouped under Rare Disease Gene Therapy on BioPharmSignal.
Which companies are most visible in the Rare Disease Gene Therapy group right now?
ABEO, AVRO, BMRN, CCBS are among the companies currently shown on this sector page.
How can I watch news for Rare Disease Gene Therapy?
Use the Watch button on this page to subscribe to Rare Disease Gene Therapy headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Rare Disease Gene Therapy?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Rare Disease Gene Therapy.